F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy

Clin Nucl Med. 2002 Feb;27(2):142-3. doi: 10.1097/00003072-200202000-00019.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Fluorodeoxyglucose F18*
  • Humans
  • Lymphoma, B-Cell / complications
  • Lymphoma, B-Cell / diagnostic imaging
  • Lymphoma, B-Cell / therapy
  • Lymphoma, Non-Hodgkin / complications
  • Lymphoma, Non-Hodgkin / diagnostic imaging*
  • Lymphoma, Non-Hodgkin / therapy*
  • Male
  • Middle Aged
  • Parotid Neoplasms / diagnostic imaging*
  • Parotid Neoplasms / therapy*
  • Radiopharmaceuticals
  • Rituximab
  • Sjogren's Syndrome / complications*
  • Tomography, Emission-Computed*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Rituximab